Clin2
NCT07416110Possibly a fitNot yet recruiting

Testing different batches of the rabies vaccine in healthy adults

Rabies (Healthy Volunteers)

Part of Infections clinical trials.

This trial tests whether different batches of a rabies vaccine produce the same immune response. You would receive the vaccine and have blood tests to check your antibody levels, helping ensure the vaccine works consistently.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
912 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be between 18 and 45 years old.
  • You must be in generally good health (stable chronic conditions allowed if well managed).
  • You must not have been bitten or scratched by a mammal (like a dog or cat) with broken skin in the past year.
  • You must never have received a rabies vaccine before.
  • If you are a woman of childbearing age, you must agree to use effective birth control during the trial and not donate eggs. Men must not donate sperm.
  • You must not be pregnant, breastfeeding, or planning to become pregnant during the trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07445815Not yet recruiting· Phase 2
Testing a lab-made antibody for rabies prevention in healthy adults

This trial tests a new rabies-prevention medicine made in a lab. It is for healthy people, not those who have been bitten, and aims to see if the injection is safe and how the body handles it.

Lanzhou, Gansu
NCT07055893Not yet recruiting· Phase 3
Rabies vaccine for preventing infection after exposure

This study tests a new rabies vaccine given after a possible exposure to rabies (like a bite) to see how well it works and how safe it is. The vaccine is given in a series of shots to help your body fight the rabies virus.

Rawalpindi
NCT07455318Not yet recruiting· Phase 3
Rabies vaccine booster after pre-exposure doses

This study tests whether a single booster dose of the rabies vaccine is still effective in people who received the primary pre-exposure series several years ago. It compares three different vaccine regimens to see which one boosts immunity best.

Antwerp
NCT07500207Enrolling by invitation· Phase 3
Rabies vaccine trial for people aged 10 to 60

This trial tests a new lyophilized rabies vaccine to see how well it works and how safe it is. It is for people who have not been vaccinated against rabies recently and have not been bitten or scratched by an animal that broke the skin in the past year.

Neijiang, Sichuan
NCT07168018Not yet recruiting· Phase 2
Testing a new rabies vaccine with the standard one

This study tests whether a new experimental rabies vaccine, when given with the standard rabies vaccine, is safe and helps the body build a strong immune response. It aims to find a better way to protect against rabies.

Bagamoyo
NCT07055880Not yet recruiting· Phase 2
Rabies vaccine doses for adults 18 to 59

This trial tests different doses of a rabies vaccine to see how well they protect against rabies and how safe they are. It's for healthy adults who may need rabies protection, for example after an animal bite or as routine prevention.

Karachi

Hear when a new Rabies (Healthy Volunteers) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.